Micafungin

Therapeutic

Treatment of candida

Structural features

SMILES

CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O

Sequence

XXTXXXX

Molar mass

1270.28 g/mol

Constitutional members:

7

Natural amino acids

1

D-Amino acids

0

N-terminus

4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl-benzoyl

C-terminus

cycle

Cyclic

yes

Members/cycle

6

Bond to form cycle

head-to-side chain (Hyp-Orn)

Lipidation

yes

Glycosylation

no

Route of administration

IV

Terminal half-life

14-17 hours

Protein binding

0.99

Absorption and Bioavailability

Not absorbed orally

References